SUTRO BIOPHARMA, INC. (STRO) Shareholders’ equity 2016–2025
SUTRO BIOPHARMA, INC. (STRO) shareholders’ equity at each fiscal year-end, per SEC filings.
-$132.5MFY2025 · since FY2016: -$90.9M → -$132.5M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$132.5M | -397.0% |
| FY2024 | $44.6M | -70.2% |
| FY2023 | $149.6M | -31.1% |
| FY2022 | $217.0M | -14.1% |
| FY2021 | $252.6M | -23.9% |
| FY2020 | $332.0M | +239.6% |
| FY2019 | $97.8M | -25.7% |
| FY2018 | $131.5M | +220.7% |
| FY2017 | -$109.0M | -19.9% |
| FY2016 | -$90.9M | — |
Source: SEC XBRL filings · For reference only · Not investment advice